Oncology
Gastroenteropancreatic Neuroendocrine Tumors
Expert Roundtables Podcast: Individualizing Therapy for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors
In this segment, the experts illustrate how individualizing therapy truly relies on multidisciplinary input and shared decision making.
Del Rivero J, Perez K, Kennedy EB, et al. Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline. J Clin Oncol. 2023;41(32):5049-5067. doi:10.1200/JCO.23.01529
Eads JR, Halfdanarson TR, Asmis T, et al. Expert consensus practice recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms. Endocr Relat Cancer. 2023;30(8):e220206. doi:10.1530/ERC-22-0206
Strosberg JR, Al-Toubah T, El-Haddad G, Reidy Lagunes D, Bodei L. Sequencing of somatostatin-receptor–based therapies in neuroendocrine tumor patients. J Nucl Med. 2024;65(3):340-348. doi:10.2967/jnumed.123.265706
Explore More in Gastroenteropancreatic Neuroendocrine Tumors
Gastroenteropancreatic Neuroendocrine Tumors
The Multimodal Treatment of Gastroenteropancreatic Neuroendocrine Tumors and Available Data on Combinatorial Strategies
Gastroenteropancreatic Neuroendocrine Tumors
Treating Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors of Higher Biological Aggressiveness
Gastroenteropancreatic Neuroendocrine Tumors
Alpha-Particle Peptide Receptor Radionuclide Therapy: Ongoing Clinical Trials
Gastroenteropancreatic Neuroendocrine Tumors